secretion by isolated perfused livers and isolated hepatocytes from control and streptozotocin diabetic rats have been investigated. 3H-Leucine and 14C-glucosamine incorporation were used as markers for protein and glycoprotein synthesis and secretion. Total protein secretion was reduced by 50% in the perfusate (p <0.001) and by 36% in hepatocytes (p <0.05), but glycoprotein secretion was unchanged in both preparations from diabetic animals. These differences were not due to changes in the available pool sizes of the different labels. On liver fractionation, all membrane components from the liver of diabetic animals had lowered 3H-leucine:14C-glucosamine ratios in relation to the control animals. This was caused by enhanced glucosamine incorporation in relation to that of leucine. It is suggested that whereas protein synthesis is decreased in acutely diabetic rats, the production of glycoproteins is normal and occurs by the same pathway as in control animals.
Glycoproteins exist as both secretory and structural components in the liver cell. The protein backbone is synthesized on membrane-bound ribosomes and glycosidation takes place on the rough membranes, smooth membranes and in the Golgi apparatus by glucosyltransferase enzymes [1] . In diabetes mellitus the capillary basement membrane is thickened probably due to the deposition of material largely cornposed of glycoprotein. Spiro has shown that in the kidney of diabetic rats there is an increase in glucosyltransferase activity [2, 3] . He suggests that there is a preferential channelling of glucose into metabolic pathways independent of insulin activity. Information concerning the liver is of special interest since this organ is responsible for the synthesis of the majority of the plasma glycoproteins [4] . Glycoprotein synthesis by the isolated perfused liver and hepatocytes serves as a model of both secretion [5] and incorporation into subcellular membranes. In this paper, using such systems, we compare the synthesis of proteins and glycoproteins by livers from control and diabetic animals.
Materials and Methods

Animals and Diet
Male rats of the Hebrew University strain, weighing 250-300 g were fed a semi-purified sucrose-rich diet consisting of 20% vitamin-free casein, 60% sucrose, 5% lard, 1% vitamin mixture, 4% salt mixture and 10% cellulose [6] . The rats were fed this diet for three weeks prior to induction of diabetes. Streptozotocin (40 rag/ kg body weight) was injected into the tail vein, as previously described [7] . Experiments were performed on fed rats 2-4 days after the streptozotocin injection. In all the diabetic animals blood glucose concentration was over 350 mg/dl.
Liver Perfusion
Isolated liver perfusion was performed as described by Mortimore et al. [8] . The perfusate consisted of Krebs-Ringer bicarbonate solution, pH 7.4, containing glucose 4g/l, streptomycin 0.1 g/l, penicillin 1000 000 U/l, 30 g/1 bovine serum albumin, a mixture of the naturally occurring aminoacids (excluding leueine) 0.1 mmol/l of each, and heparin 1000 U/1. Human red blood cells, washed twice with 0.154mol/1 saline, were added to the perfusate to achieve a haematocrit of approximately 20%. The liver was washed first with 40 ml Krebs-Ringer bicarbonate solution. It was then perfused in a recycling system with a volume of 60-70 ml.
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Throughout the perfusion, sodium palmitate complexed to serum albumin (4 : 1 molar ratio) was infused into the portal vein at a rate of 0.2 retool/h, using a constant perfusion pump [9] . Oxygenation with 95% 02, 5% CO2, was carried out as described by Hamilton et al. [10] using silastic tubing (Dow-Corning, Michigan). At zero time, 50 ~tCi of 3H-leucine and 10 ~tCi of 14C-glucosamine were added to the perfusate immediately after the wash. Samples of the perfusate were taken for the determination of the leucine and glucosamine incorporation into proteins at zero time, and every 30 rain thereafter for 3 h.
Preparation of the Subcellular Fractions
In order to isolate the labelled subcellular-organelle membranes, fractionation of the perfused livers was performed 3 h after the addition of the radioactive markers [4] . At this time the liver was removed, weighed and homogenized. The Golgi apparatusenriched fraction was isolated according to Morre and co-workers [11] . The purity of this fraction was verified by electron microscopy and marker enzyme determination. Enzyme activity of UDP-galactose ovalbumin galactosyltransferase was measured in all the subcellular fractions by the method of Hodson and Brenchley [12] and was found principally in the Golgi apparatus enriched fraction. The activity was concentrated seventy-fold in this fraction when compared to the other membrane fractions. Mitochondria were prepared from the 2000 x g supernatant according to Sottocasa et al. [13] . Smooth membranes, rough membranes, polysomes and post-microsomal supernatant fractions were prepared according to Sunshine et al. [14] except that the MgC12 concentration of the gradient buffers was increased from 5 to 10 mmol/1 (Dice and Schimke [15] ). Protein radioactivity of the erythrocyte free perfusate, hepatocytes and liver fractions was determined by the method of Mans and Novelli [6] . 100 ~tl samples were placed on labelled filter papers (Whatman 3MM) allowed to dry for a few minutes and then dropped in 5% TCA solution (5 ml/paper) at 4 ~ After all the samples had been taken, the filter papers were washed successively in 5% TCA at 50 ~ cold TCA, ethanol and ether (1 : 1 v/v) and finally ether. The papers were dried in air and then transferred to counting vials containing 10 ml scintillation fluid (Toluene : PPO : POPOP). The radioactivity was measured in a liquid scintillation counter (Packard Instrument Co., model 3380).
Hepatocyte Preparation
Hepatocytes were prepared according to the method of Zahlten and Stratman [17] using eollagenase. Incubations were made in 5.0 x 2.5 cm glass scintillation vials over a period of 2 h. The reaction mixture, in a total volume of 1.0 ml, was based on calcium-free Krebs-Henseleit buffer [18] with gelatin. The mixture contained 2-3 • 10 6 cells; NaC1 118.6 p~mol; KCI 1.19~tmol; KH2PO 4 1.19 ~tmol; MgSO 4 1.1 ~mol; NaHCO 3 24.5 ~mol; gelatin 15 mg; L-4,5-3H-leucine 0.02 ~tmol (5.0 ~zCi); D-1-14C-glucosamine 0.0068 ~xmol (0.35 mxCi). The calcium ion concentration of the incubation medium was derived from the gelatin and ranged between 0.5-0.7 mmol/1 [19] . The vials were gassed continuously with 95% 02 and 5% CO 2 in a shaking water bath at 37 ~ without any preincubation. Aliquots were taken at timed intervals from the total incubation mixture, cells and supernatant (after centrifugation). The integrity of the hepatocytes was confirmed by their ability to perform gluconeogenesis from dihydroxyacetone and from their response to glucagon. Viability was assessed by trypan blue exclusion which was observed consistently in 85-95% of the cells. Conversion from the number of hepatocytes to g wet liver weight was calculated according to the method of Zahlten and Stratman [17] .
Determination of Pool Sizes of Leucine and Glucosamine
The validity of the incorporation results depends on the available pool sizes of leucine and glucosamine in diabetic and non-diabetic rats. These were derived from the method of de Fernandez Sese and Scornik [20] , assuming a rapid equilibration between the extracellular and intracellular concentrations of these precursors [21] . Known concentrations of leucine and glucosamine were added to the hepatocytes and the rates of their incorporation into TCA precipitable material were measured. It was then possible to calculate the dilution factors (which approximate to the "available pool sizes") by the standard isotope dilution equation [22, 23] .
where: y = the quantity of non-labelled leucine or glucosamine added (known); x = the quantity of radioactive label added (known); d = the amount of non-labelled leucine or glucosamine present intracellularly which dilutes the added label (= the dilution factor); C o = the count rate of the TCA precipitate in the medium when only the radioactive label is added, cpm/min (known); C =the count rate of the TCA precipitate in the medium after the addition of non-labelled leucine or glucosamine to an identical reaction mixture, cpm/min (known).
By changing the amount of (y), different count rates (C) were measured, and then a graph was plotted of (y) against (~ -2-~ -1) . The gradient is equal to (x + d).
In each experiment the amount of only one label substrate was altered. There was no change in the incorporation of one label in the presence of varying concentrations of the other (leucine or glucosamine) (not shown).
The dilution factors (d) were derived from the gradients, and the available pool sizes were calculated from the initial concentrations of leucine and glucosamine of 20 mmol/1 and 6.8 retool/1 respectively. There was no difference in the dilution factor for leucine between diabetic and non-diabetic rats.
The available pool size of leucine in both diabetic and nondiabetic rats was found to be between 80 and 90 mmol/1. The glucosamine pool in the diabetic animals was 3.7 mmol/1 as compared to 1.4 mmol/1 in the non-diabetic animals. These results were calculated from three diabetic and three non-diabetic preparations.
L-4,5-3H-leucine 60.0 Ci/mmol and D-l-14C-glucosamine 59.0 mCi/mmol were purchased from the Radiochemical Centre, Amersham, England. Streptozotocin was kindly supplied by Dr. W. Dulin of Upjohn Co., Kalamazoo, Mich., USA. Bovine serum albumin (Fraction V powder, essentially fatty acid free) was purchased from Sigma, St. Louis, U.S.A. Collagenase (CLS II) was supplied by Worthington Biochemical Corporation, New Jersey, U.S.A. Aminoacids were obtained from Nutritional Biochemical Corporation, Cleveland, Ohio, U.S.A.
The Student t-test (two-tailed) was used to evaluate the significance of differences between the means in the groups studied. All results are expressed as mean +_ SEM.
Results
The synthesis and secretion of total proteins and glycoproteins by livers from diabetic and control ant- Figure 1A . There was a lag period of 15-30 min which preceded the secretion of proteins into the perfusate in both preparations but the rate of protein secretion by the diabetic liver was markedly decreased. Figure 1 B shows that, in contrast to total protein secretion, glycoprotein production, as measured by 14C-glucosamine incorporation into TCA precipitate from the perfusate, was not significantly altered in the diabetic rat livers. The rates of incorporation of the radioactive labels are given in Table 1 . The lowered 3H-leucine: 14C-glucosamine ratio in the diabetic preparations is due principally to the decrease in incorporation of leucine by 50%. In the isolated hepatocytes the synthesis of proteins and glycoproteins was found to be linear over an incubation period of 120 min. However there was also a latent period of approximately 30 rain before secretion of labelled materials could be demonstrated in the medium. The rate of incorporation of 3H-leucine and 14C-glucosamine was measured both in the medium (secreted proteins) and in the cells ( Table 2 ). The rate for each label was calculated during the linear incorporation period as the TCA precipitable cpm per unit time.
Considering secreted proteins from the hepatocytes there was a decrease in 3H-leucine incorporation in the diabetic animals by 36% whereas the incorporation rate of ~4C-glucosamine was unaf- fected. However, in the cellular proteins from the hepatocytes there were similar incorporation rates for the two labels.
The effect of different glucose concentrations in the medium on the incorporation of glucosamine into proteins is shown in Figure 2 . Neither the incorporation of ~4C-glucosamine nor 3H-leucine was altered by the addition to the incubation mixture of glucose in concentrations up to 10 mmol/l. At 20 mmol/1 there was a slight decrease in incorporation. The incorporation of 14C-glucosamine relative to 3H-leucine in both the supernatant and cells was unaffected by glucose concentration. In other words, there was no isotopic dilution of glucosamine by the concentrations of intracellular glucose found in the standard incubations. These varied between 1.0 and 3.0 mmol/1.
Liver fractionation was performed to compare the incorporation of radioactive labels into the membrane-bound proteins of the liver (Table 3) . With the exception of the homogenate and the post microsomal supernatant, the incorporation of ~4C-glucosamine in the separate membrane fractions was higher in the diabetic preparations. However, the relative distribution of glycoproteins among the different subcellular fractions was similar in the diabetic and control livers. In both groups the highest 3H-leucine: 14C-glucosamine incorporation ratio was found in the post-microsomal supernatant and the lowest in the Golgi apparatus-enriched fraction.
Discussion
Reports of enhanced glycoprotein production in diabetes [24] correlate with the pronounced capillary basement membrane thickening characteristic of this disease. As this latter process is considered to be an integral part of microangiopathy responsible for the major pathological complications, study of glycoprotein synthesis in the liver of diabetic animals is of considerable importance.
Liver perfusion of streptozotocin diabetic rats provides a suitable system for such investigations. Fortyeight hours after a single injection of the drug there is a decrease in insulin levels, with hyperglycaemia and hyperlipidaemia [6] . Reaven and Reaven [25] have shown that the ultrastructural appearance of the liver is well preserved in streptozotocin-treated rats after this time interval.
Protein synthesis by the liver is decreased in chronic diabetes induced in rats by partial pancreatectomy or alloxan injection [26, 27] . This has been confirmed in our experiments in acutely diabetic rats by the decrease in incorporation of 3H-leucine into secretory proteins. By contrast we observed that incorporation of 14C-glucosamine into secretory glycoproteins was not significantly reduced. Glucosamine was chosen as a marker for glycoprotein synthesis as it is not extensively catabolized and is largely incorporated into glycoproteins [4] . In hepatocytes the pattern of synthesis of secreted proteins was similar to that found in the liver perfusion studies. There was however no difference in the synthesis rate of non-secretory proteins (cellular) in hepatocytes from diabetic and control animals ( Table 2) .
The available leucine pool size of 80-90 ~tmol compares with that of 72 pmol found by Schreiber and Schreiber [21] in normal male Buffalo rats fed on a different diet. The glucosamine pool size was larger in diabetic animals. This is in contrast to the finding of Spiro [28] that the pools were similar in the plasma and liver in alloxan-diabetic and control rats. The method of calculation and the type of preparation were not analogous. The present results are not surprising and may even be predicted from Spiro's own hypothesis of alternative channelling of glucose in diabetes. Whichever is correct, the overall conclusion is unaltered. Incorporation of glucosamine into proteins was apparently unaffected by diabetes mellitus.
The amount of radioactive glucosamine incorporated into proteins depends not only on dilution by the glucosamine pool but also on the synthesis of glucosamine from intracellular glucose. On the one hand this might be expected to be higher in the diabetic animals because their plasma glucose levels are higher and its entry into hepatocytes is indepen- Figure 2 show no isotopic dilution of glucosamine by glucose. However, since the glucosamine pool sizes are increased then glycoprotein synthesis is evidently more accentuated than indicated by the uncorrected incorporation results (Figure 1 B and the incorporation data given in the Tables). The similar pattern of incorporation ratios in secreted proteins from liver perfusions and from hepatocytes, suggests that the pool size calculations are also representative of the situation in the perfused livers. There would thus be true differences in protein synthesis and glycosylation between nondiabetic and diabetic rats.
Since glycoproteins are both secreted and membrane bound, we measured the incorporation of 3H-leucine and 14C-glucosamine in the different cellular fractions. In the non-diabetic liver, glycoproteins are found in the various membrane organelles in which they undergo synthesis, secretion, or incorporation into structural proteins. There are no free glycoproteins in the cytosol [1] . In each membrane containing fraction from the diabetic livers there was more incorporation of glucosamine in relation to leucine (as shown by the lowered 3H-leucine: 14C-glucosamine ratio); but the distribution of glycoproteins among the different organelles was similar in the two groups of rats. This suggests that diabetes does not per se alter the pattern of normal glycoprotein synthesis, secretion, and incorporation into the various organelles (Table 3) . Further, there appears to be increased glucosamine incorporation into the membrane and secreted proteins in the liver of diabetic rats by the normal pathway. These results may be in accord with Spiro's hypothesis of increased glycoprotein synthesis in diabetes [2] , and provide experimental support for the clinical observation of increased levels of liver-derived plasma glycoproteins in diabetic subjects [30] . These proteins may produce alterations in the basement membranes of the kidney. Recently it has been shown in mice that multiple injections of glycosylated plasma proteins can cause pseudodiabetic renal glomerular changes [31] .
In the diabetic rat there is thus an absolute decrease in protein synthesis but no change in the incorporation of glucosamine into glycoproteins. These findings may be explained in a number of ways. In the diabetic liver there may be no decrease in the synthesis of the protein backbone of the glycoproteins in comparison with the other proteins, and these proteins are glycosylated normally. Alternatively, if the decrease in protein synthesis extends to glycoproteins as well, it must be assumed that there is excessive glycosylation of glycoproteins. Another possible explanation is that there is an increase in total glycoprotein synthesis, perhaps involving gly-cosylation of protein not normally bearing carbohydrate residues.
Isolated perfused liver and hepatocytes preparations serve as useful models for the study of the metabolic events responsible for the increase in glycoprotein synthesis in diabetes. Agents which interfere with glycoprotein production can be studied in these systems to determine whether it may be possible to modify the development of diabetic microangiopathy.
